Radiotherapy Followed by Adjuvant Chemotherapy in NK/T-cell Lymphoma

• Status: Unknown status
• Trial end date: 2016-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate the efficacy and tolerability of radiotherapy followed by adjuvant chemotherapy in stage I/II NK/T-cell lymphoma.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Fudan University

Criteria

Inclusion Criteria:

• Age range 14-70 years old

• Histological confirmed, previously untreated stage I/II NK/T cell lymphoma in the upper-aerodigestive tract

• ECOG performance status 0-1

• Life expectancy of more than 3 months

• Without prior history of pancreatitis

• Adequate bone marrow and organ functions

Exclusion Criteria:

• Low risk population (Definition: stage I without local invasion, B symptoms and high LDH level)

• Pregnant or lactating women

• With contraindication of steroid including uncontrolled diabetes

• Serious uncontrolled diseases and intercurrent infection

• History of other malignancies except cured basal cell carcinoma of skin and carcinoma in-situ of uterine cervix